Partner

JD, Suffolk University Law School
PhD Neurobiology, Harvard University
BS Biology, University of Michigan

Registered to practice before the U.S. Patent and Trademark Office
Admitted to the bar in Massachusetts

Michael Belliveau has been at Clark & Elbing since 1998 and a partner since 2006. His work involves patent prosecution and opinion work, including assisting in the preparation of patentability, non-infringement, and freedom-to-operate opinions. Michael works with clients to protect innovations related to small molecule therapeutics for the treatment of bacterial and fungal infections, cancer, neurological disorders, and inflammation; drug discovery; molecular diagnostics; DNA and protein chip-based technologies; stem cells; and human gene therapy. He also performs patent due diligence analyses for venture capital investors.

Michael’s doctoral research employed cellular and molecular techniques, confocal microscopy, and fluorescence-activated cell sorting to study neural progenitor cell specification and differentiation. The results of these studies were published in Development and Journal of Neuroscience.